Design Therapeutics, Inc. (DSGN): SCHEDULE 13D/A filed Nov 18, 2025

Form type

SCHEDULE 13D/A

Filing date

Nov 18, 2025

Accession number

0000935836-25-000710

Filer

Design Therapeutics, Inc. (CIK 1807120)